SEERAD

Seer is a commercial-stage life sciences company focused on democratizing proteomics by enabling the detection of novel biological insights through deep, unbiased, and rapid analysis of the proteome. The company's flagship Proteograph Product Suite utilizes proprietary engineered nanoparticles to capture a broad range of proteins across the dynamic range of the proteome, which are then analyzed using standard mass spectrometry. This technology allows researchers to identify thousands of proteins and their variants from complex samples like blood, facilitating the discovery of biomarkers and therapeutic targets. Seer aims to bridge the gap between genomics and phenotypic outcomes by providing a scalable solution for large-scale proteomic studies.